The Role of Chitinase-3-like Protein-1 (YKL40) in the Therapy of Cancer and Other Chronic-Inflammation-Related Diseases.
Ming-Cheng ChangChun-Tang ChenPing-Fang ChiangYing Cheng ChiangPublished in: Pharmaceuticals (Basel, Switzerland) (2024)
Chitinase-3-like protein-1 ( CHI3L1 ), also known as YKL40, is a glycoprotein that belongs to the chitinase protein family. It is involved in various biological functions, including cell proliferation and tissue remodeling, with inflammatory and immunomodulatory capabilities. Several studies have shown that CHI3L1 (YKL40) is upregulated in various diseases, such as cancer, asthma, and inflammatory bowel disease, among others. Although the expression level of CHI3L1 (YKL40) is associated with disease activity, severity, and prognosis, its potential as a therapeutic target is still under investigation. In this review, we summarize the biological functions, pathological roles, and potential clinical applications of specific inhibitors and targeted therapies related to CHI3L1 (YKL40).
Keyphrases
- disease activity
- papillary thyroid
- rheumatoid arthritis
- cell proliferation
- systemic lupus erythematosus
- oxidative stress
- squamous cell
- rheumatoid arthritis patients
- chronic obstructive pulmonary disease
- ankylosing spondylitis
- juvenile idiopathic arthritis
- lymph node metastasis
- stem cells
- squamous cell carcinoma
- lung function
- mesenchymal stem cells
- signaling pathway
- pi k akt
- air pollution
- young adults
- protein protein
- long non coding rna
- allergic rhinitis
- bone marrow
- replacement therapy